Merck Prinivil (lisinopril)
Executive Summary
Merck Prinivil (lisinopril): FDA determines a regulatory review period of 2,373 days for the ACE inhibitor, which is comarketed by Stuart under the Zestril brand. Comments and petitions should be submitted to FDA Dockets branch by Oct. 12.